Search
Asthma Paid Clinical Trials in Connecticut
A listing of 3 Asthma clinical trials in Connecticut actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 3 of 3
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Asthma
Filter by Age
Filter by Type
Gender
Type of Study
Clinical Trial Phase
The state of Connecticut currently has 3 active clinical trials seeking participants for Asthma research studies. These trials are conducted in various cities, including New Haven, Hartford, Farmington and Stamford.
Featured Trial
Asthma A Clinical Study
Recruiting
A clinical study for people that suffer with Asthma A
Conditions:
Asthma A
Featured Trial
Asthma Clinical Study
Recruiting
A clinical study for people that suffer with Asthma
Conditions:
Asthma
Featured Trial
Healthy Participants Needed (Colonoscopy + Cancer Screening)
Recruiting
Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
Conditions:
Healthy
Healthy Volunteers
Healthy Subjects
Healthy Volunteer
Healthy Participants
Featured Trial
Heart failure clinical study is now enrolling
Recruiting
Are you interested in a clinical study exploring an investigational medicine for heart failure, also known as HF? The MARITIME-HF clinical study is testing an investigational medicine to see if it can reduce HF-related symptoms and risk of hospitalization in people living with HF and obesity.
Researchers are focused on developing a potential option for reducing HF-related symptoms. By participating, you may contribute to research that may offer benefits for those in the future in need of a different way to manage their HF.
Answer just a few questions to submit your information and see if you may qualify
Researchers are focused on developing a potential option for reducing HF-related symptoms. By participating, you may contribute to research that may offer benefits for those in the future in need of a different way to manage their HF.
Answer just a few questions to submit your information and see if you may qualify
Conditions:
Heart Failure
Congestive Heart Failure
Chronic Heart Failure
Heart Failure
Congestive
Featured Trial
Lose Weight with Tirzepatide
Recruiting
Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to tirzepatide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
Semaglutide and Tirzepatide are advanced GLP-1 medications designed to support weight management and metabolic health. They work by targeting GLP-1 receptors in the body, helping regulate appetite, improve blood sugar control, and support sustainable weight loss.
Semaglutide and Tirzepatide are advanced GLP-1 medications designed to support weight management and metabolic health. They work by targeting GLP-1 receptors in the body, helping regulate appetite, improve blood sugar control, and support sustainable weight loss.
Conditions:
Overweight
Overweight and Obesity
Featured Trial
Obesity (w/ CVD or T2DM) Clinical Study
Recruiting
A clinical study for people that suffer with Obesity (w/ CVD or T2DM)
Conditions:
Obesity (w/ CVD or T2DM)
Community Health Equity Accelerator (CHEA) Pediatric Asthma Intervention
Recruiting
The purpose of this pilot is to initiate an academic-community partnership and launch a multi-level intervention that includes an asthma exposure pathway (an online decision support and resource) and a health Promotora program that will provide culturally responsive asthma support alongside legal and medical services to improve access to asthma care and ultimately improve asthma-related outcomes in the New Haven region.
Gender:
ALL
Ages:
Between 4 years and 11 years
Trial Updated:
07/11/2025
Locations: Yale, New Haven, Connecticut
Conditions: Asthma in Children
A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations
Recruiting
A dose range-finding study to assess the efficacy and safety of multiple dose levels of AZD8630 administered via a dry powder inhaler in adults with uncontrolled asthma at risk of exacerbations, receiving medium -to -high dose inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA).
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
06/16/2025
Locations: Research Site, New Haven, Connecticut
Conditions: Asthma
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
Recruiting
In this study, a new method will be used to evaluate response to 2 approved biologic therapies, and assess how well each patient responds to each asthma treatment. This study will measure the response to these treatments using genomic and biologic measurements obtained from participants biosamples.
By evaluating response to 2 different biologic therapies, this study has the potential to provide an in-depth understanding of the mechanisms underlying severe asthma that will inform and change trea... Read More
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
08/16/2024
Locations: Yale University, New Haven, Connecticut
Conditions: Moderate to Severe Asthma